Colposcopy and management of microinvasive squamous cell carcinoma

Minerva Ginecologica

Volumn 64, Issue 2, 2012, Pages 121-136

  Costa, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Colposcopy; Recurrence; Risk factors; Therapeutics; Uterine cervical neoplasms

Indexed keywords

CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COLPOSCOPY; CYTOPATHOLOGY; HISTOPATHOLOGY; HUMAN; LYMPHOVASCULAR SPACE INVASION; MICRO INVASIVE CERVICAL CANCER; NONHUMAN; PROGNOSIS; REVIEW; UTERINE CERVIX CANCER;

ADULT; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CONIZATION; ELECTROCOAGULATION; FEMALE; HUMANS; HYSTERECTOMY; LASERS; MASS SCREENING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; WATCHFUL WAITING;

EID: 84862738463     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Mesrwerd G. Die fruhdiagnose des Kollumkarzinoms. Zentrablatt für Gynäkologie 1947;69:198-202.
2. Maiman MA, Fruchter RG, DiMaio TM, Superficially invasive squamous cell carcinoma of the cervix Obstet Gynecol 1988;72:399-403.
3. Burghardt E, Mestwerdt G, Ober KG. Der Unterschied zwischen der Einstufung Zervixkrebs des stadiums Ia und dem Begriff Mikrokarzinom. Geburtshilfe Frauenheilkd 1973;33:168-72.
4. Marsden DE, Hacker NF, Edwards L. The management of microinvasive carcinoma. In Jordan JA, Singer A. Maiden, USA: Blackwell Publishing, The cervix, II Edition; 2006. p. 531-9.
5. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
6. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105:107-8.
7. Ostor AG, Rome RM. Micro-invasive squamous cell carcinoma of the cervix: a clinico-pathologic study of 200 cases with long term follow-up. Int J Gynecol Cancer 1994;4:257-64.
8. Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 1999;78:478-85.
9. National statistics: Cancer trends in England and Wales; 1950-1999.
10. Sigurdsson K. Cervical cancer: cytological cervical screening in Iceland and implications of HPV Vaccines Cytopathology 2010;21:213-22.
11. Kolstad P. Follow up study of 232 patients with stage 1A1 and 411 patients with stage 1A2 squamous cell carcinoma of the cervix. Gynaecol Oncol 1989;33-265-72.
12. Orlandi C, Costa S, Terzano P. Presurgical assessment and therapy of microinvasive carcinoma of the cervix. Gynecol Oncol 1995;59:255-60.
13. Costa S, Marra E, Martinelli G, Santini D, Casadio P, Formelli G et al. Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer 2009;19:33-8.
14. Cairns M, Cruickshank M. Treatment and follow-up of women with microinvasive cervical cancer. Rev Gynecol Perinatal Pract 2006;6:126-32.
15. Sasieni P, Cuzick J, Lynch-Farmery E. Estimating the efficiency of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer 1996;73:1001-5.
16. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93.
17. Sykes P, Reddy J, PeddieD. Does regular cervical screening protect women from microinvasive squamous cell carcinoma of the cervix? A retrospective case-controlled study BJOG 2005;112:807-9.
18. Miller GM, Sung HY, Sawaya GF, Kearney KA, Kinney W, Hiatt RA. Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2003;101:29-37.
19. Simcock B, Sykes P, Laney M. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury. NZ Med J 2001;114:378-80.
20. Independent Monitoring Group of the National Cervical Screening Programme. Quarterly Report 2 National Cervical Screening Programme January-March 2001. Dunedin: University of Otago; 2001. p. 19-27.
21. Coleman D., Day N., Dongias G.,FattneryE., Lynge E., Philip G., Segnan N. European Guidelines for Quality Assurance in Cervical Cancer Screening. Eur J Cancer 1993;29/A S1
22. Marquardt K, Büttner HH, Broschewitz U, Barten M, Schneider V. Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause. Acta Cytol 2011;55:433-7.
23. Apgar B, Brotzman G, Spitzer M. Colposcopy: principles and practice. WB. Saunders, Philadelphia; 2002. p. 279-82.
24. Paraskevaidis E, Kitchener HC, Miller ID, Mann E, Jandial L, Fisher PM. A population-based study of microinvasive disease of the cervix - a colposcopic and cytologic analysis. Gynecol Oncol 1992;45:9-12.
25. Costa S, Syrjanen K. Gestione delle pazienti con Pap test anormale. Modena: Athena; 2005.
26. Burghardt E. Pathology of early invasive squamous and glandular carcinoma of the cervix. In: Coppleson M, editor. Gynecologic Oncology. London: Churchill Livingstone; 1992. p. 609-29.
27. Tidbury P, Singer A, Jenkins D. CIN3; the role of lesion size in invasion. Br J Obstet Gynaecol 1992;99:583-6.
28. Histology Reporting in Cervical Screening. Working party of the Royal college of Pathologists and the NHS Cervical Screening Programme. NHSCSP publication no. 10; April 1999.
29. Chi DS, Abu-Rustum NR, Plante M, Roy M. Cancer of the cervix. In Te Linde's operative gynecology. Rock JA, Jones HW, Editors, 1227-1290. Philadelphia: Lippincott Williams & Wilkins; 2008.
30. Siverberg S, Ioffe O. Pathology of cervical cancer. Cancer J 2003;9:335-47.
31. Raspagliesi F, Ditto A, Quattrone P, Solima E, Fontanelli R Dousias V. Prognostic factors in microinvasive cervical squamous cancer: long term results. Int J Gynecol Cancer 2005;15:88-93
32. Costa S, De Nuzzo M, Rubino A. Independent determinants of inaccuracy of colposcopically directed punch biopsy of the cervix. Gynaecol Oncol 2003;90:57-63.
33. Leman MH Jr, Benson WL, Kurman RJ, Park RC. Microinvasive carcinoma of the cervix. Obstet Gynecol 1976;48:571.
34. Benson WL, Norris HJ. A critical review of the frequency of lymph node metastasis and death from microinvasive carcinoma of the cervix. Obstet Gynecol 1977;49:632-8.
35. Sedlis A, Sall S, Tsukada YL. Microinvasive carcinoma of the uterine cervix: a clinical-pathologic study. Am J Obstet Gynecol 1979;133:64-74.
36. Sevin BU. Management of microinvasive cervical cancers. Semin Surg Oncol 1999;16:228-31.
37. Morgan PR, Anderson MC, Buckley CH. The Royal College of Obstetricians and Gynaecologists; microinvasive carcinoma of the cervix study: preliminary results. Br J Obstet Gynaecol 1993,100:664-8.
38. Paraskevaidis E, Kitchener HC, Miller ID, Mann E, Jandial L, Fisher PM. A population-based study of microinvasive disease of the cervix - a colposcopic and cytologic analysis. Gynecol Oncol 1993;45:9-12.
39. Paraskevaidis E, Kitchener H, Kalantaridou S, Agnanti N, Lolis D. Large loop conisation for early invasive cervical cancer. Int J Gynecol Cancer 1997;7:95-9.
40. Histology Reporting in Cervical Screening. Working party of the Royal college of Pathologists and the NHS Cervical Screening Programme. NHSCSP publication no. 10; April 1999.
41. Siverberg S, Ioffe O. Pathology of cervical cancer. Cancer J 2003; 9:335-47.
42. Mota F.. Microinvasive squamous carcinoma of the cervix: treatment modalities. Acta Obstet Gynecol Scand 2003;82:505-9.
43. Gadducci A, Sartori E, Maggino T, Landoni F, Zola P, Cosio S et al. The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study. Eur J Gynaecol Oncol 2003;24:513-6.
44. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989;35:314-20.
45. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992;70:648-55.
46. Koliopoulos G, Sotiriadis A, Kyrgiou M, Martin-Hirsh P, Makrydimas G, Paraskevaidis E. Conservative surgical methods for FOGO stage IA2 squamous cervical Carcinoma and their role in preserving women's fertility. Gynecol Oncol 2004,93:469-73.
47. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage Ib sq uamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352.
48. Averette HE, Nguyen HN, Donato DM. Radical hysterectomy for early invasive cervical cancer: a 25-year prospective experience with the Miami technique. Cancer 1993;71:422-37
49. Jones WB, Mercer GO, Lewis JL Jr, Rubin SC, Hoskins WJ. Early invasive carcinoma of the cervix. Gynecol Oncol 1993;51:26-32.
50. Buckley SL, Tritz DM, Van Le L. Lymph node metastases and prognosis in patients with stage Ia2 cervical cancer. Gynecol Oncol 1996;63:4-9.
51. Barber BR, Sommers SC, Rotterdam H, Kwon T. Vascular invasion as a prognostic factor in stage Ib cancer of the cervix. Obstet Gynecol 1978;52:343-8.
52. Ostor A. Pandora's Box or Ariadne's Thread? Definition and prognostic significance of microinvasion in the uterine cervix. Pathol Ann 1995;30:103-36.
53. Holzer E, Microinvasive carcinoma of te cervix - clinical aspects, treatment and follow-up. In: E. Burghardt and E. Holzer, Editors, Minimal invasive cancer (microcarcinoma). Clinical oncology 2. London: WB Saunders; 1982. p. 315-52.
54. Benedet J, Bender H, Jones H, Nban H, Pecorelli S. FIGO staging classifications and clinical practice guidelines of gynaecological cancers. Int J Gynaecol Obstet 2000;70:207-312.
55. Lohe KJ, Burghardt E, Hillemanns HG, Kaufmann C, Ober KG, Zander J. Early squamous cell carcinoma of the uterine cervix. II. Clinical results of a cooperative study in the management of 419 patients with early stromal invasion and microcarcinoma. Gynecol Oncol 1978,6:31-50.
56. Morgan PR, Anderson MC, Buckley CH, Murdoch JB, Lopes A, Duncan ID et al. The Royal College of Obstetricians and Gynaecologists micro-invasive carcinoma of the cervix study: preliminary results. Br J Obstet Gynaecol 1993;100:664-8.
57. Ostor AG. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993;12:193-207.
58. Creasman WT, Kohler MF Gynecologic Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Oncology 2004,92:525-9.
59. J.R. Van Nagell, N. Greewell, D.F. Powell, E.S. Donaldson, M.B. Hanson and E.C. Gay, Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983;145:981-91.
60. Larson G, Alm P, Gullberg B, Grundsell H. Prognostic factors in early invasive carcinoma of the uterine cervix. A clinical, histopathologic, and statistical analysis of 343 cases. Am J Obstet Gynecol 1983;146:145-53.
61. Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer 1980;5:928-31.
62. Sevin BU, Nadji M, Averette HE. Microinvasive carcinoma of the cervix. Cancer 1992;70:2121-8.
63. Pearson S, Whittaker J, Ireland D, Monaghan J. Invasive cancer after cervix laser treatment. Br J Obstet Gynaecol 1989;96:486-9.
64. Anderson M, Invasive carcinoma of the cervix following local destructive treatment for cervical intrapithelial neoplasia. Br J Obstet Gynaecol 1993;100:657-63.
65. Girardi F, Heydarfadai M, Koroschetz F, Pickel H, Winter R. Cold knife, conization versus loop excision: histhopathologic and clinical results of a randomized trial. Gynecol Oncol 1994;55:368-70.
66. Mathevet P, Dargent D, Roy M, Beau G. A randomized prospective study comparing three techniques of conization: cold knife, laser, and leep. Gynecol Oncol 1994;54:175-9.
67. Oyesanya O, Amerasinghe C, Manning E. Outpatient excixional management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1993;168:485-8.
68. Duggan BD, Felix JC, Muderspach LL. Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. Am J Obstet Gynecol1999;180:276-82.
69. Tseng C, Liang C, Lin C. A study of diagnostic failure of loop conization in microinvasive carcinoma of the cervix. Gynecol Oncol 1999;73:91-5.
70. Roman LD, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol 1997;90:759-64.
71. Anderson E, Neisen K, Pedersen B. Combination laser conization as treatment of microinvasive carcinoma of the uterine cervix. Euro J Gynaecol Oncol 1998;19:352.
72. Stehman FB, Rose PG, Greer BE. Innovations in the treatment of invasive cervical cancer. Cancer 2003;98:2052-63.
73. Tseng C, Horng S, Soong Y, Hsueh S, Hseih C, Lin H. Conservative conisation for microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1997;175:1009-10.
74. Morris M, Mitchell M, Silvo E, Copeland L, Gershenson D. Cervical conisation as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecologic Oncol 1993;51:193-6.
75. Diakomanolis E, Haidopoulos D, Rodolakis A, Vlachos G, Stefanidis K, Komisopoulos K et al. Laser CO2 conization: a safe mode of treating conservatively microinvasive carcinoma of the uterine cervix. Eur J Obstet 2004;113:223-9.
76. Benedet J, Anderson G. Stage 1A carcinoma of the cervix revisited. Obstet Gynecol 1996;87:1052-9.
77. Dargent D, Martin X, Sacchetoni A, Mathevet P.Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer. 2000;88:1877-82.
78. Dargent D. Radical abdominal trachelectomy and pelvic lymphadenectomy with uterine conservation and subsequent pregnancy in the treatment of early invasive cervical cancer. Am J Obstet Gynecol 2002;187:192.
79. Plante M, Renaud M, Francois H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An update of 72 case and review of the literature. Gynecol Oncol 2004;94:614-23.
80. Roy M, Plante M. Pregnancies after radical vaginal hysterectomy for early stage cervical cancer. Am J Obstet Gynecol 1998;179:1491-6.
81. Plante M, Renaud M, Hoskins I, Roy M. Vaginal radical trachelectomy: a valuable fertility preserving option in the management of early stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 2005;98:3-10.
82. Ungar L, Palfalvi L, Hogg R Siklos P, Boyle D, Priore G et al. Abdominal radical trachelectomy: a fertility preserving option for women with early cervical cancer. BJOG 2005;112:366-9.
83. Lee C, Huang K, Lai C. Laparoscopic radical trachelectomy for Stage 1B1 cervical cancer. J Am Assoc Gynecol Laparosc 2003;10:111-5.
84. Kinney W, Hodge D, Egorshin E, Ballard D, Podratz K. Identification of a low-risk subset of patients with stage 1B invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol 1995;57:3-6.
85. Winters R, Haas J, Reich O, Koemetter R, Tamussino K, Lahousen M et al. Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes. Gynecol Oncol 2002;84:252-7.
86. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G et al. How important is removal of the parametrium at surgery of carcinoma of the cervix? Gynecol Oncol 2002;84:145-9.
87. Soutter W, de Barros Lopes A, Fletcher A, Monaghan J, Duncan I, Paraskevaidis E et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-80.
88. Elfgren K, Bistoletti P, Diller L, Walboomers J, Meijer C, Dillner J. Conisation for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol 1996;174:937-42.
89. Chua K, Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 1997;66:108-13.
90. Zielinski G, Bais A, Heimerhorst T, Verheijen RH, de Schipper FA, Snijders PJ et al. HPV testing and monitoring of women after treatment of CIN3: review of literature and metanalysis. Obstet Gynecol Surv 2004;59:543-53.
91. Das N, Naik R, Jackson S, De Barros Lopes A, Monaghan JM, Godfrey KA et al. Recurrent smear abnormalities where repeat loop treatment is not possible: is hysterectomy the ansewer? Gynecol Oncol 2005;97:751-4.
92. Morice P, Dargent D, Haie-Meder C, Duvillared P, Castaigne D. First case of a centropelvic recurrence after radical trachelectomy: literature review and implications of preoperative selection of patients. Gynecol Oncol 2004;92:1002-5.
93. Kew F, Roberts A, Cruickshank D. The role of routine follow-up after gynaecological malignancy. Int J Gynaecol Cancer 2005;15:413-9.
94. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 2003,90:358-65.
95. Soutter W, de Barros Lopes A, Fletcher A, Monaghan J, Duncan I, Paraskvaidis E. Invasive cervical cancer after conservative therapy for cervical cancer after conservative therapy for cervical intraepitehelia neoplasia. Gynecol Oncol 2005,99:S7-11.
96. Venturoli S, Ambretti S, Cricca M, Leo E, Costa S, Musiani M, Zerbini M. Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment. J Med Virol. 2008;80:1434-40
97. Cairns M, Cuschieri K, Cubie, H, Cruickshank ME. High-Risk HPV Genotyping in the Follow-Up of Women Treated Conservatively for Microinvasive Cervical Cancer International Journal of Gynecological Cancer 2010;20:154-7.
98. Koskimaa HM, Kurvinen K, Costa S, Syrjänen K, Syrjänen S. Molecular markers implicating early malignant events in cervical carcinogenesis. Cancer Epidemiol Biomarkers Prev 2010;19:2003-12.